NOILE-IMMUNE BIOTECH
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
NOILE-IMMUNE BIOTECH
Industry:
Biotechnology
Founded:
2015-04-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.noile-immune.com
Total Employee:
11+
Status:
Active
Total Funding:
3.44 B JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Font Awesome Apache Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Investors List
Shibuya Kogyo
Shibuya Kogyo investment in Series C - Noile-Immune Biotech
Dai-ichi Life
Dai-ichi Life investment in Series C - Noile-Immune Biotech
BiGEN
BiGEN investment in Series C - Noile-Immune Biotech
Binex
Binex investment in Series C - Noile-Immune Biotech
Healthcare Innovation
Healthcare Innovation investment in Series C - Noile-Immune Biotech
Yamaguchi Technology Licensing Organization
Yamaguchi Technology Licensing Organization investment in Corporate Round - Noile-Immune Biotech
BiGEN
BiGEN investment in Venture Round - Noile-Immune Biotech
DCI Partners
DCI Partners investment in Venture Round - Noile-Immune Biotech
Sosei CVC
Sosei CVC investment in Venture Round - Noile-Immune Biotech
SAIKYO
SAIKYO investment in Venture Round - Noile-Immune Biotech
Official Site Inspections
http://www.noile-immune.com Semrush global rank: 2.71 M Semrush visits lastest month: 6.07 K
Unable to get host informations!!!
More informations about "Noile-Immune Biotech"
English TOP- Noile-Immune Biotech Inc.
Welcome to Noile-Immune BiotechNoile-Immune Biotech is a clinical stage biotechnology company focused on the development and commercialization of novel cancer immunotherapy …See details»
Our Business - noile-immune.com
Noile-Immune Biotech Inc. runs a business to develop safe and effective drugs for solid tumors employing state-of-art cancer immunotherapy with CAR-T cells using PRIME technology. …See details»
Noile-Immune Biotech - Crunchbase Company Profile & Funding
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from …See details»
Chugai and Noile-Immune Biotech Enter into a License Agreement …
Aug 22, 2022 · Noile-Immune Biotech Inc., established as a university start-up, aims to contribute to the arrival of an era when we can overcome cancer through the next-generation cancer …See details»
Alliance between Noile-Immune Biotech, Inc. and Rebirthel Co., …
Apr 24, 2023 · Rebirthel and Noile-Immune Biotech announce that they have entered into a contract on collaborative research and commercialization of next-generation gene-modified …See details»
Noile-Immune Biotech - Biotech Careers
Noile-Immune Biotech is a clinical stage biotechnology company focused on the development and commercialization of next generation CAR-T cells to eradicate solid cancers. Business Areas: …See details»
Noile-Immune Biotech Inc, 4893:TYO profile - FT.com - Financial …
Nov 5, 2024 · Noile-Immune Biotech Inc (4893:TYO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Noile-Immune Biotech - Contacts, Employees, Board Members
Noile-Immune Biotech is a national cancer research center specializing in the development of cancer immunotherapies.See details»
Impact Investment in Noile-Immune Biotech, Inc.
Has impact invested JPY 500 million in Noile-Immune Biotech, Inc. ("Noile-Immune"; President & CEO: Koji Tamada), a Japanese startup that develops innovative cancer immunotherapy. This …See details»
Our Mission - ノイルイミューン・バイオテック株式会社
Cancer immunotherapy holds promise for patients to defeat cancer with their immune system. Noile-Immune Biotech aims to create truly effective cancer immunotherapy through pioneering …See details»
Adaptimmune pens backloaded deal to access T-cell tech
Aug 27, 2019 · Adaptimmune has struck a deal to access Noile-Immune Biotech’s technology for improving cancer cell therapies. The collaboration, which could cost Adaptimmune $312 …See details»
Moffitt Study Shows How Cancer Cell Death May Harm the …
2 days ago · TAMPA, Fla. — A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in …See details»
4893 Stock Price Quote | Morningstar
Nov 15, 2024 · See the latest Noile-Immune Biotech Inc stock price (4893:XTKS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Adaptimmune and Noile-Immune to Develop SPEAR T-Cell Products
Aug 27, 2019 · Adaptimmune Therapeutics (NASDAQ: ADAP) announced on Tuesday (August 27) it will be partnering with Japan-based Noile-Immune Biotech to create specific peptide …See details»
English TOP- Noile-Immune Biotech Inc.
Welcome to Noile-Immune BiotechNoile-Immune Biotech is a clinical stage biotechnology company focused on the development and commercialization of novel cancer immunotherapy …See details»
NIB103の開発におけるタカラバイオ株式会社との業務提携に関す …
Sep 25, 2024 · 固形がんに対するCAR-T細胞療法の研究開発を行うノイルイミューン・バイオテック株式会社（東京都港区、代表取締役社長：玉田耕治、以下、ノイルイミューン）は、本 …See details»
About Us - noile-immune.com
Our goal is to discover and develop innovative cancer immunotherapies through partnerships with experts in academia including National Cancer Center (NCC) in Japan.See details»
ノイルイミューン・バイオテック株式会社の会社情報と資金調達 …
Mar 9, 2023 · Noile-Immune Biotech Inc. 【バイオベンチャー】国立がん研究センターと山口大学発ベンチャー。がん免疫療法を開発する。See details»
Heterozygote advantage can explain the extraordinary diversity of ...
2 days ago · We here present an eco-evolutionary model showing that evolution can result in the emergence and maintenance of more than 100 alleles under HA if the following two …See details»
Leadership/ Governance - ノイルイミューン・バイオテック ...
Our company seeks to improve management efficiency as well as the soundness, transparency, and compliance of our operations. We work to increase corporate value based on the …See details»